Glipizide ER (extended release) is a medication used to treat type 2 diabetes. It is a sulfonylurea drug, which works by stimulating the pancreas to produce more insulin. It is a long-acting form of glipizide, which is a generic drug. Glipizide ER is a once-daily medication that helps to control blood sugar levels. It is often used in combination with other diabetes medications, such as metformin or insulin. The aim of this article is to provide a comprehensive review of glipizide ER, including its effectiveness, side effects, and safety.
Glipizide ER is an extended-release form of glipizide, a generic drug. It works by stimulating the pancreas to produce more insulin. Insulin is a hormone that helps the body use glucose from carbohydrates in the food we eat for energy or to store glucose for future use. Glipizide ER is usually taken once daily, usually in the morning. It is usually taken with food to reduce the risk of low blood sugar.
Studies have shown that glipizide ER is effective in controlling blood sugar levels in people with type 2 diabetes. In a 12-week study of over 400 people with type 2 diabetes, glipizide ER was found to be more effective than placebo in reducing fasting blood glucose levels. In another study of over 500 people with type 2 diabetes, glipizide ER was found to be more effective than placebo in reducing HbA1c levels.
Like all medications, glipizide ER can cause side effects. Common side effects include nausea, headache, dizziness, and diarrhea. Less common side effects include skin rash, weight gain, and abdominal pain. Rare side effects include low blood sugar (hypoglycemia) and an allergic reaction.
Glipizide ER is generally safe when taken as directed. It is important to follow the instructions of your healthcare provider when taking this medication. It is also important to monitor your blood sugar levels regularly and to report any changes to your healthcare provider.
In conclusion, glipizide ER is an effective medication for controlling blood sugar levels in people with type 2 diabetes. It is usually taken once daily and is usually taken with food to reduce the risk of low blood sugar. Common side effects include nausea, headache, dizziness, and diarrhea. It is important to follow the instructions of your healthcare provider and to monitor your blood sugar levels regularly.
1.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
2.
An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.
3.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
4.
Breast cancer surgery: Study finds overnight hospital stay not important for older patients
5.
As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.
1.
New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results
2.
Exploring the Latest Treatments for Essential Thrombocythemia
3.
Colon cancer: Risk factors, warning signs and treatment options
4.
Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder
5.
Tertiary Lymphoid Structures: Pivotal Players in Cancer Prognosis and Therapeutic Response
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Thromboprophylaxis In Medical Settings- An Update
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation